Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Chinese Patent Office
Federal Trade Commission
Accenture
Queensland Health
Daiichi Sankyo
Moodys
Mallinckrodt
US Army
Fuji

Generated: June 24, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 022387

« Back to Dashboard

NDA 022387 describes TYVASO, which is a drug marketed by United Therap and is included in one NDA. It is available from one supplier. There are seven patents protecting this drug and one Paragraph IV challenge. Additional details are available on the TYVASO profile page.

The generic ingredient in TYVASO is treprostinil. There are seventeen drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the treprostinil profile page.
Summary for 022387
Tradename:TYVASO
Applicant:United Therap
Ingredient:treprostinil
Patents:7
Pharmacology for NDA: 022387
Ingredient-typeProstaglandins I
Physiological EffectVasodilation
Suppliers and Packaging for NDA: 022387
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
TYVASO treprostinil SOLUTION;INHALATION 022387 NDA United Therapeutics Corp. 66302-206 N 66302-206-01
TYVASO treprostinil SOLUTION;INHALATION 022387 NDA United Therapeutics Corp. 66302-206 N 66302-206-02

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:SOLUTION;INHALATIONStrength0.6MG/ML
Approval Date:Jul 30, 2009TE:RLD:Yes
Patent:➤ Try a Free TrialPatent Expiration:Nov 13, 2018Product Flag?Substance Flag?Delist Request?
Patented Use:TREATMENT OF PULMONARY HYPERTENSION BY INHALATION
Patent:➤ Try a Free TrialPatent Expiration:Nov 13, 2018Product Flag?Substance Flag?Delist Request?
Patented Use:TREATMENT OF PULMONARY HYPERTENSION BY INHALATION
Patent:➤ Try a Free TrialPatent Expiration:Dec 15, 2028Product Flag?Substance Flag?YDelist Request?Y

Expired US Patents for NDA 022387

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
United Therap TYVASO treprostinil SOLUTION;INHALATION 022387-001 Jul 30, 2009 ➤ Try a Free Trial ➤ Try a Free Trial
United Therap TYVASO treprostinil SOLUTION;INHALATION 022387-001 Jul 30, 2009 ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Fish and Richardson
Dow
Colorcon
AstraZeneca
Cantor Fitzgerald
US Army
Farmers Insurance
Citi
Julphar

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.